COLUMBIA, Md.--(BUSINESS WIRE)--Celsion Corporation (NASDAQ: CLSN), a biotechnology drug development company that is leveraging its heat sensitive liposomal technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics, will hold its Annual Meeting of Stockholders on Friday, May 15, 2009 at 10:00 AM ET at Baltimore Marriott Waterfront, 700 Aliceanna Street, Baltimore, MD 21202.
